Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritis

Osteoarthritis and Cartilage

Volumn 16, Issue 11, 2008, Pages 1277-1288

  Brien, S ^a   Prescott, P ^a   Bashir, N ^a   Lewith, H ^a   Lewith, G ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Dimethyl sulfoxide; DMSO; Methylsulfonylmethane; MSM; Osteoarthritis; Systematic review

Indexed keywords

CELECOXIB; DICLOFENAC; DIMETHYL SULFONE; DIMETHYL SULFOXIDE; GLUCOSAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO;

APPLICATION SITE DESQUAMATION; APPLICATION SITE DRYNESS; BLOATING; BURNING SENSATION; CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; COMBINATION CHEMOTHERAPY; CONCENTRATION LOSS; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DIARRHEA; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY SKIN; DYSPEPSIA; EMBASE; FATIGUE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HALITOSIS; HUMAN; INDIGESTION; INFORMATION RETRIEVAL; INSOMNIA; KNEE OSTEOARTHRITIS; KNEE PAIN; LOW DRUG DOSE; MEDLINE; MONOTHERAPY; NAUSEA; OPTIMAL DRUG DOSE; PARESTHESIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; SKIN MANIFESTATION; SKIN ODOR; SKIN REDNESS; SYSTEMATIC REVIEW; TASTE; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VOMITING;

ANTI-INFLAMMATORY AGENTS; DIETARY SUPPLEMENTS; DIMETHYL SULFOXIDE; FREE RADICAL SCAVENGERS; HUMANS; OSTEOARTHRITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SULFONES;

EID: 53849143607     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2008.03.002     Document Type: Review

References (63)

1. Sangha O. Epidemiology of rheumatic diseases. Rheumatology 39 Suppl 2 (2000) 3-12
2. Moskowitz R.W., Abramson S.B., and Berenbaum F. Coxibs and NSAIDs - clearing the air. Osteoarthritis Cartilage 13 7 (2005) 545-547
3. Bjordal J.M., Ljunggren A.E., Klovning A., and Slordal L. Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritis knee: meta-analysis of randomised placebo controlled trials. BMJ 329 (2000) 1317-1322
4. Arellano F.M. The withdrawal of refocoxib. Pharmacoepidemiol Drug Saf 14 3 (2005) 213-217
5. Eisenberg D.M., Davis R., Ettner S.L., Appel S., Wilkey S., and Rompay M.V. Trends in alternative medicine use in the United States, 1990-1997. JAMA 280 (1998) 1569-1575
6. Rao J.K., Mihaliak K., Kroenke K., Bradley J., Tierney W., and Weinberger M. Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 131 6 (1999) 409-416
7. Herman C.J., Allen P., Hunt W.C., Prasad A., and Brady T.J. Use of complementary therapies among primary care clinic patients with arthritis. Prev Chronic Dis 1 4 (2004 Oct) 1-15. Available from: URL: (Serial online)
8. Deal C.L., and Moskowittz R.W. Neutriceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondrotin sulphate and collagen hydrolysate. Rheum Dis Clin North Am 25 (1999) 379-395
9. Ameye L.G., and Chee W.S. Osteoarthritis and nutrition: from nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther 8 4 (2006) R127
10. Anonymous. Methylsulfonylmethane (MSM). Monograph. Altern Med Rev 8 4 (2003) 438-441
11. Cronin J.R., and Ballen K. The biochemistry of alternative therapies: methylsulfonylmethane: nutraceutical of the next century?. J Altern Complement Med 5 6 (1999) 386-389
12. Demos C.H., Beckloff G.L., Donin M.N., and Oliver P.M. DMSO in musculoskeletal disorders. Ann N Y Acad Sci 141 (1967) 517-523
13. Jimenez R.A., and Willkens R.F. Dimethyl sulphoxide: a perspective of its use in rheumatic diseases. J Lab Clin Med 100 (1982) 489-500
14. Trice J.M., and Pinals R.S. Dimethyl sulphoxide: a review of its uses in the rheumatic disorders. Semin Arthritis Rheum 15 1 (1985) 45-60
15. Rosenstein E.D. Topical agents in the treatment of rheumatic disorders. Rheum Dis Clin North Am 25 4 (1999) 899-918
16. Ely A., and Lockwood B. What is the evidence for the safety and efficacy of dimethyl sulfoxide and methylsulfonylmethane in pain relief?. Pharm J 269 (2002) 685-687
17. Evans M.S., Reid K.H., and Sharp J.B. Dimethylsulfoxide (DMSO) blocks conduction in peripheral nerve C fibers: a possible mechanism of analgesia. Neurosci Lett 150 (1993) 145-148
18. Muir M. DMSO: many uses, much controversy. Altern Complement Ther (1996) 230-235
19. Jacob S.W., and Herschler R. Dimethyl sulfoxide after twenty years. Ann N Y Acad Sci 411 (1983) 14-18
20. Beilke M.A., Collins-Lech C., and Sohnle P.G. Effects of dimethyl sulphoxide on the oxidative function of human neutraphils. J Lab Clin Med 110 (1987) 91-96
21. Paulus E. FDA advisory committee meeting: methotrexate; guidelines for the clinical evaluation of anti-inflammatory drugs; DMSO in scleroderma. Arthritis Rheum 29 (1986) 1289-1290
22. Murav'ev IuV., Venikova M.S., Pleskovskaia G.N., Riazantseva T.A., and Sigidin laA. Effect of dimethylsulphoxide and dimethyl sulfone on a destructive process in the joints of mice with spontaneous arthritis. Patol Fiziol Eksp Ter 2 (1991) 37-39
23. Brayton C.F. Dimethyl sulfoxide (DMSO) a review. Cornell Vet 76 1 (1986) 61-90
24. Ebisuzaki K. Asprin and methylsulphonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention. Anticancer Res 23 (2003) 453-458
25. Alam S.S., and Layman D.L. Dimethyl sulphoxide inhibition of prostacylin production in culture aortic endothelial cells. Ann N Y Acad Sci 411 (1983) 318-320
26. Fox R.B., and Fox W.K. Dimethyl sulphoxide prevents hydroxyl radical mediated depolymerisation of hyaluronic acid. Ann N Y Acad Sci 411 (1983) 13-17
27. Morton J., and Moore R. Lupus nephritis and deaths are diminished in B/W mice drinking 3% water solution of dimethyl sulphoxide or dimethyl sulfone. J Leuko Biol 40 (1986) 322
28. Hasegawa T. Suppressive effects of methylsulfonylmethane (MSM) on type II collagen induced arthritis in DBA/1J mice. Jpn Pharmacol Ther 32 (2004) 421-427
29. Rizzo R., Grandolfo M., Godeas C., Jones K.W., and Vittur F. Calcium, sulphur and zinc distribution in normal and arthritic equine cartilage: a synchronton radiation induced X ray emission (SRIXE). J Exp Zool 273 (1995) 82-86
30. Parcell S. Sulfur in human nutrition and applications in medicine. Altern Med Rev 7 1 (2002) 22-44
31. Bookman A.A., Williams S., and Shainhouse J.Z. Effects of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ 171 4 (2004) 333-338
32. Brown J.H. Clinical experience with DMSO in acute musculoskeletal conditions comparing a non controlled series with a controlled double blind study. Ann N Y Acad Sci 141 (1967) 496-505
33. Kolb K.H., Jaenicke G., Kramer M., and Schulze P.E. Absorption, distribution, and elimination of labelled dimethyl sulfoxide in man and animals. Ann N Y Acad Sci 141 (1967) 85-95
34. Vuopala U., Isomaki H., and Kaipainen W.J. Dimethyl sulfoxide (DMSO) ointment in the treatment of rheumatoid arthritis. A double blind study. Acta Rheumatol Scand 15 (1969) 139-144
35. Micromedex health care series. Available from:.
36. Natural Medicine Comprehensive Database. 5th edn. (2003), Therapeutic Research Faculty, California
37. Usha P.R., and Naidu M.U.R. Randomised double blind, parallel, placebo controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clin Drug Investig 24 6 (2004) 353-363
38. Kim L.S., Axelrod L.J., Howard P., Buratovich N., and Waters R.F. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage 14 (2006) 286-294
39. Jacobs S., Lawrence R.M., and Siegel M. Miracle MSM: the Natural Solution for Pain (1999), GP Putnam, NY
40. Patent storm. Available from:.
41. 35S] methylsulfonylmethane following oral administration to rats. J Agric Food Chem 55 3 (2007) 1033-1038
42. 35S radioisotope tracer method. Nutr Res 22 (2002) 313-322
43. Horvath K., Noker P.E., Somfai-Relle S., Glavits R., Financsek I., and Schauss A.G. Toxicity of methylsulphonylmethane in rats. Food Chem Toxicol 40 (2002) 1459-1462
44. Magnuson B.A., Appleton J., Ryan B., and Matulka R.A. Oral developmental toxicity study of methylsulfonylmethane in rats. Food Chem Toxicol 45 6 (2007) 977-984
45. Jadad A., Moore A., Carroll D., Jenkinson C., Reynolds D.J.M., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary. Control Clin Trials 17 (1996) 1-12
46. Roth S.H., and Shainhouse J.Z. Efficacy and safety of a topical diclofenac solution (Pennsaid) in the treatment of primary osteoarthritis of the knee. Arch Intern Med 164 (2004) 2017-2023
47. Koenen N.J., Haag R.F., Bia P., and Rose P. Perkutane therapie bei aktivierter Gonarthrose. Munch Med Wochenschr 138 31/32 (1996) 534-538
48. Eberhardt R., Zwingers T., and Hofmann R. DMSO bei Patienten mit aktivierter Gonathrose. Eine doppeblinde, plazebokontrollierte Phase III Studie. Fortschr Med 113 (1995) 446-450
49. Vuopala U., Vesterinen E., and Kaipainen W.J. The analgesic action of dimethyl sulfoxide (DMSO) ointment in arthrosis. Acta Rheum Scand 17 (1971) 57-60
50. Geba G.P., Weaver A.L., Polis A.B., Dixon M.E., and Schnitzer T.J. Efficacy of rofecoxib, celecoxib and acetaminophen in osteoarthritis of the knee: a randomised trial. JAMA 287 (2002) 64-71
51. Swanson B. Medical use of dimethylsulphoxide. Rev Clin Basic Pharm 5 (1985) 1-33
52. Muravyev Y., Sigidin Y., Alyabyeva A., Ivanov E., Mitrofanov V., Zhadenov I., et al. A multicentre study of the effectiveness of dimethyl sulphoxide in rheumatoid and degenerative arthritis. Ter Arkh (1987) 106-108
53. Rosenbaum E.E., Herschler R.J., and Jacob S.W. DMSO in musculoskeletal disorders. JAMA 192 (1965) 309-313
54. Steinberg A. The employment of DMSO as an anti-inflammatory agent and steroid transported in diversified clinical diseases. Ann N Y Acad Sci 141 (1967) 532-550
55. Marmor L., and Walike B. Experience with DMSO. Calif Med 105 (1966) 28-30
56. Bennett R.M., Kappes J., Kessler S., et al. Dimethylsulphoxide does not suppress an experimental model of arthritis in rabbits. J Rheumatol 10 (1983) 533-538
57. Smith G., Bertone A.L., Kaeding C., et al. Anti-inflammatory effects of topically applied dimethyl sulphoxide gel on endotoxin-induced synovitis in horses. Am J Vet Res 59 (1998) 1149-1152
58. Trentham D.R., and Rowland D. Dimethyl sulphoxide does not suppress the clinical manifestations of collagen arthritis. J Rheumatol 10 (1983) 114-116
59. Curtis C.L., Harwood J.L., Dent C.M., and Caterson B. Biological basis for the benefit of nutriceutical supplementation in arthritis. Drug Discov Today 9 (2004) 165-172
60. Singh G. Recent considerations in non-steroidal anti-inflammatory drug gastropathy. Am J Med 105 1B (1998) 31S-38S
61. Figueras A., Capella D., Castel J.M., and Laporte J.R. Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol 47 (1994) 297-303
62. Pirmonhammed M., James S., Meakin S., Green C., Scott A.K., Walley T.J., et al. Adverse drug reactions as cause of admission to hospital prospective analysis of 18 820 patients. BMJ 329 (2004) 15-19